Analysis of clinical outcomes according to response status in prospective clinical trials of atezolizumab (atezo) in pretreated locally advanced/metastatic urothelial carcinoma (mUC) Meeting Abstract
| Authors: | Bedke, J.; Merseburger, A. S.; Loriot, Y.; Castellano, D.; Choy, E.; Duran, I.; Rosenberg, J. E.; Petrylak, D. P.; Dreicer, R.; Perez-Gracia, J. L.; Hoffman-Censits, J. H.; Van Der Heijden, M. S.; Degaonkar, V.; Thiebach, L.; de Ducla, S.; Fear, S.; Powles, T.; Sternberg, C. N. |
| Abstract Title: | Analysis of clinical outcomes according to response status in prospective clinical trials of atezolizumab (atezo) in pretreated locally advanced/metastatic urothelial carcinoma (mUC) |
| Meeting Title: | 2020 Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2020 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-02-20 |
| Language: | English |
| ACCESSION: | WOS:000529525900520 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.6_suppl.492 |
| Notes: | Meeting Abstract: 492 -- Source: Wos |
